Stephen Kilmer | IR |
Daniel White | CEO |
Richard Beckman | Chief Medical Officer |
Glen Noronha | Chief Scientific Officer |
Charles Deignan | CFO |
Boris Peaker | Cowen & Co |
Eric Joseph | JP Morgan |
Serge Belanger | Needham & Company |
Good morning, ladies and gentlemen and welcome to the Clearside Biomedical Third Quarter 2017 Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] I would now like to turn the call over to your host for today’s conference Mr. Steve Kilmer, Investor Relations for Clearside Biomedical.